Author

M. A. Antonyak

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:human· 3 Research Focus:cancer & tumor microenvironment· 2 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:drug response / drug discovery· 1 Assay:proteomics· 1

Frequent Co-Authors

R. A. Cerione· 3 shared F. Wang· 2 shared A. L. Jayathilake· 1 shared A. Latifkar· 1 shared B. D. Regalado· 1 shared C. A. Reinhart-King· 1 shared C. Fischbach· 1 shared C. M. Carlson· 1 shared

Activity by Year

2021-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

R. A. Cerione

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Proteomic analysis reveals microvesicles containing NAMPT as mediators of radiation resistance in glioma

E. Panizza, B. D. Regalado, F. Wang, I. Nakano, N. M. Vacanti, R. A. Cerione, M. A. Antonyak

The paper identifies NAMPT-containing microvesicles as mediators of radiation resistance in glioma stem cells through proteomic analysis.

bioRxiv · Mar 23, 2022Cancer Biology

Weakly migratory metastatic breast cancer cells activate fibroblasts via microvesicle-Tg2 to facilitate dissemination and metastasis

S. C. Schwager, L. A. Hapach, C. M. Carlson, J. A. Mosier, T. J. McArdle, W. Wang, A. L. Jayathilake, F. Bordeleau, M. A. Antonyak, R. A. Cerione, C. A. Reinhart-King

This study shows weakly migratory breast cancer cells use microvesicle-Tg2 to activate fibroblasts, promoting metastasis through tumor stiffening and fibroblast activation.

bioRxiv · Oct 27, 2021Cancer Biology

IGF2BP2 Promotes Cancer Progression by Degrading the RNA Transcript Encoding a v-ATPase Subunit

A. Latifkar, F. Wang, J. J. Mullmann, I. R. Fernandez, L. Ling, C. Fischbach, R. S. Weiss, H. Lin, R. A. Cerione, M. A. Antonyak

The paper shows that IGF2BP2 degradation of ATP6V1A transcript, driven by SIRT1 down-regulation and acetylation, impairs lysosomal function and promotes cancer progression.

bioRxiv · Apr 1, 2021Cell Biology